Loss-making Dade Behring plans to shed low profile and improve communications in its "investment year"
This article was originally published in Clinica
Executive Summary
Dade Behring, which has a unique position among big company laboratory diagnostics companies in that it is effectively privately-owned, is to abandon its policy of reticence in communicating with the outside world. It even concedes that its communications with its small, core group of bondholders - institutions that have invested in Dade Behring's debt - have not hitherto been good.